260
Views
18
CrossRef citations to date
0
Altmetric
Original Research

The HLA-B*13:01 and the dapsone hypersensitivity syndrome in Korean and Asian populations: genotype- and meta-analyses

ORCID Icon, ORCID Icon, ORCID Icon, , , , ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon & show all
Pages 1349-1356 | Received 12 Jun 2020, Accepted 14 Jul 2020, Published online: 18 Aug 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Abdelbaset A. Elzagallaai & Michael J. Rieder. (2022) Genetic markers of drug hypersensitivity in pediatrics: current state and promise. Expert Review of Clinical Pharmacology 15:6, pages 715-728.
Read now
Thawinee Jantararoungtong, Therdpong Tempark, Napatrupron Koomdee, Sadeep Medhasi & Chonlaphat Sukasem. (2021) Genotyping HLA alleles to predict the development of Severe cutaneous adverse drug reactions (SCARs): state-of-the-art. Expert Opinion on Drug Metabolism & Toxicology 17:9, pages 1049-1064.
Read now

Articles from other publishers (16)

Zihao Mi, Hong Liu & Furen Zhang. (2023) Advances in the pathogenic, genetic and immunological studies of leprosy. hLife.
Crossref
Qing Zhao, Lele Sun, Yonghu Sun, Dean NaisbittHong Liu & Furen Zhang. (2023) Dapsone hypersensitivity syndrome. Chinese Medical Journal 136:13, pages 1560-1562.
Crossref
Chun-Bing Chen, Wei-Kai Hung, Chuang-Wei Wang, Chih-Chun Lee, Shuen-Iu Hung & Wen-Hung Chung. (2023) Advances in understanding of the pathogenesis and therapeutic implications of drug reaction with eosinophilia and systemic symptoms: an updated review. Frontiers in Medicine 10.
Crossref
Chih-Hsuan Wung, Chuang-Wei Wang, Kuo-Chu Lai, Chun-Bing Chen, Wei-Ti Chen, Shuen-Iu Hung & Wen-Hung Chung. (2023) Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs. Frontiers in Pharmacology 14.
Crossref
Mubarak Almutairi, Adam Lister, Qing Zhao, James Line, Kareena Adair, Arun Tailor, James Waddington, Elsie Clarke, Joshua Gardner, Paul Thomson, Nicolas Harper, Yonghu Sun, Lele Sun, David A. Ostrov, Hong Liu, David J. MacEwan, Munir Pirmohamed, Xiaoli Meng, Furen Zhang & Dean J. Naisbitt. (2023) Activation of Human CD8+ T Cells with Nitroso Dapsone–Modified HLA-B*13:01–Binding Peptides. The Journal of Immunology 210:8, pages 1031-1042.
Crossref
Andrew Gibson, Pooja Deshpande, Chelsea N. Campbell, Matthew S. Krantz, Eric Mukherjee, Maja Mockenhaupt, Munir Pirmohamed, Amy M. Palubinsky & Elizabeth J. Phillips. (2023) Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions. Journal of Allergy and Clinical Immunology 151:2, pages 289-300.e4.
Crossref
Mu-Tzu Chu, Wan-Chun Chang, Shih-Cheng Pao & Shuen-Iu Hung. (2023) Delayed Drug Hypersensitivity Reactions: Molecular Recognition, Genetic Susceptibility, and Immune Mediators. Biomedicines 11:1, pages 177.
Crossref
Haiqin Jiang, Chuang-Wei Wang, Zhaoxi Wang, Yufei Dai, Yanping Zhu, Yun-Shien Lee, Yang Cao, Wen-Hung Chung, Songying Ouyang & Hongsheng Wang. (2022) Functional and structural characteristics of HLA-B*13:01-mediated specific T cells reaction in dapsone-induced drug hypersensitivity. Journal of Biomedical Science 29:1.
Crossref
Mukul Sharma & Pushpendra Singh. (2022) Advances in the Diagnosis of Leprosy. Frontiers in Tropical Diseases 3.
Crossref
Renato de Filippis, John M. Kane, Nazar Kuzo, Edoardo Spina, Giovambattista De Sarro, Jose de Leon, Pasquale De Fazio & Georgios Schoretsanitis. (2022) Screening the European pharmacovigilance database for reports of clozapine-related DRESS syndrome: 47 novel cases. European Neuropsychopharmacology 60, pages 25-37.
Crossref
Therdpong Tempark, Shobana John, Pawinee Rerknimitr, Patompong Satapornpong & Chonlaphat Sukasem. (2022) Drug-Induced Severe Cutaneous Adverse Reactions: Insights Into Clinical Presentation, Immunopathogenesis, Diagnostic Methods, Treatment, and Pharmacogenomics. Frontiers in Pharmacology 13.
Crossref
Le Wang, Pei-Wen Sun, Mei-Wen Yu, Heng Gu, Hong-Sheng Wang & Xiang-Sheng Chen. (2022) Leprosy Update in China, 2019. International Journal of Dermatology and Venereology 5:1, pages 15-19.
Crossref
Chiraphat Kloypan, Napatrupron Koomdee, Patompong Satapornpong, Therdpong Tempark, Mohitosh Biswas & Chonlaphat Sukasem. (2021) A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine. Pharmaceuticals 14:11, pages 1077.
Crossref
Shang-Chen Yang, Chun-Bing Chen, Mao-Ying Lin, Zhi-Yang Zhang, Xiao-Yan Jia, Ming Huang, Ya-Fen Zou & Wen-Hung Chung. (2021) Genetics of Severe Cutaneous Adverse Reactions. Frontiers in Medicine 8.
Crossref
Patompong Satapornpong, Jirawat Pratoomwun, Pawinee Rerknimitr, Jettanong Klaewsongkram, Nontaya Nakkam, Thanyada Rungrotmongkol, Parinya Konyoung, Niwat Saksit, Ajanee Mahakkanukrauh, Warayuwadee Amornpinyo, Usanee Khunarkornsiri, Therdpong Tempark, Kittipong Wantavornprasert, Pimonpan Jinda, Napatrupron Koomdee, Thawinee Jantararoungtong, Ticha Rerkpattanapipat, Chuang-Wei Wang, Dean Naisbitt, Wichittra Tassaneeyakul, Manasalak Ariyachaipanich, Thapana Roonghiranwat, Munir Pirmohamed, Wen-Hung Chung & Chonlaphat Sukasem. (2021) HLA-B*13 :01 Is a Predictive Marker of Dapsone-Induced Severe Cutaneous Adverse Reactions in Thai Patients. Frontiers in Immunology 12.
Crossref
. (2020) Dapsone. Reactions Weekly 1821:1, pages 91-91.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.